Mental Health and Suicidality in Glioblastoma Patients in Germany
ConditionGlioblastoma (GBM)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Essen
About this trial
The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.
Eligibility criteria
Qualifiers
Diagnosis of glioblastoma, IDH wild-type (CNS WHO classification of 2021)
Age ≥ 18 years
Disqualifiers
Participants with clinically significant aphasia or language barrier as assessed by the investigator
History of other malignant tumors
Known tumor predisposition syndrome (e.g., Li-Fraumeni syndrome, Cowden syndrome, etc.)
Trial design
Treatments tested in this trial
- Medical history, physical examination, completing questionnaires, data collection
Treatment groups
176 Participants
are divided into 1 treatment groupSponsors and collaborators
University Hospital, Essen
Lead sponsor
University Hospital Muenster
Collaborator
Charite University, Berlin, Germany
Collaborator
University Hospital Heidelberg
Collaborator
Neurological Clinic, Knappschaftskrankenhaus Bochum-Langendreer, Bochum, Germany
Collaborator
Universitätsklinikum Hamburg-Eppendorf
Collaborator
Source ClinicalTrials.gov